The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

Benadryl has been associated with worse school performance and, in one small study, impaired people’s ability to drive more ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

Oxytocin, often called the “love hormone” for its role in social bonding and maternal behaviors, is now being investigated for something unexpected—its ability to regulate addictive behaviors and ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

MARYVILLE/GRANITE CITY/BELLEVILLE - Chestnut Health Systems will offer free virtual NARCAN training.At 10 a.m. and 2 p.m. on ...

FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...

When planning for your trip, keep possible nasal polyp triggers in mind, including changes in air pressure, exposure to ...